Home › Agent Hub › Agent Tools › Part D coverage by drug › Ubrelvy
Agent Tools
Ubrelvy is a brand of ubrogepant. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 3,627 of 5,492 Medicare Part D and Medicare Advantage drug plans (66%) list Ubrelvy on their formulary, across 215 of 286 formularies. The most common placement is tier 3 (3,180 plans, 87.7% of those covering it). 3,498 of the covering plans require prior authorization (96.4%), 24 step therapy and 3,509 a quantity limit.
423 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $42, 68 of them $0; 3,204 charge coinsurance instead — median 20% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 4,370 of 5,496 plans covered it (79.5%); 2027: 3,627 of 5,492 (66%).
Of 4,367 plans offered in both years, 16 added it to the formulary and 793 dropped it.
Among plans covering it both years, 110 moved it to a higher tier and 11 to a lower one; 15 added prior authorization and 18 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 113 |
| Tier 2 | 45 |
| Tier 3 | 3,180 |
| Tier 4 | 36 |
| Tier 5 | 253 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 130 of 323 | 40.2% | 100% |
| Medicare Advantage with drugs (MA-PD) | 2,134 of 3,200 | 66.7% | 96% |
| Special needs plans (SNP) | 1,363 of 1,969 | 69.2% | 96.8% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 3 | 846 |
| UnitedHealthcare | 0 of 830 | No tier listed | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 728 |
| Aetna Medicare | 631 of 631 | Tier 3 | 631 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 112 of 112 | Tier 3 | 16 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 83 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 74 |
| Wellpoint | 58 of 63 | Tier 3 | 58 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 3 | 37 |
| Zing Health | 36 of 36 | Tier 4 | 36 |
| Capital Blue Cross | 27 of 35 | Tier 5 | 27 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 29 |
| Medica | 1 of 27 | Tier 3 | 1 |
| Anthem HealthKeepers | 22 of 26 | Tier 3 | 22 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 5 | 26 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 73 of 114 | 64% |
| Alaska | 4 of 9 | 44.4% |
| American Samoa | 0 of 1 | 0% |
| Arizona | 107 of 147 | 72.8% |
| Arkansas | 55 of 85 | 64.7% |
| California | 269 of 397 | 67.8% |
| Colorado | 70 of 106 | 66% |
| Connecticut | 38 of 54 | 70.4% |
| Delaware | 22 of 43 | 51.2% |
| District of Columbia | 7 of 12 | 58.3% |
| Florida | 384 of 545 | 70.5% |
| Georgia | 94 of 149 | 63.1% |
| Guam | 0 of 1 | 0% |
| Hawaii | 39 of 50 | 78% |
| Idaho | 15 of 45 | 33.3% |
| Illinois | 92 of 132 | 69.7% |
| Indiana | 109 of 138 | 79% |
| Iowa | 43 of 64 | 67.2% |
| Kansas | 57 of 84 | 67.9% |
| Kentucky | 87 of 121 | 71.9% |
| Louisiana | 89 of 125 | 71.2% |
| Maine | 33 of 52 | 63.5% |
| Maryland | 37 of 49 | 75.5% |
| Massachusetts | 75 of 89 | 84.3% |
| Michigan | 120 of 182 | 65.9% |
| Minnesota | 22 of 63 | 34.9% |
| Mississippi | 54 of 104 | 51.9% |
| Missouri | 128 of 170 | 75.3% |
| Montana | 17 of 27 | 63% |
| Nebraska | 30 of 51 | 58.8% |
| Nevada | 64 of 100 | 64% |
| New Hampshire | 15 of 25 | 60% |
| New Jersey | 49 of 73 | 67.1% |
| New Mexico | 27 of 68 | 39.7% |
| New York | 123 of 215 | 57.2% |
| North Carolina | 118 of 176 | 67% |
| North Dakota | 10 of 26 | 38.5% |
| Northern Mariana Islands | 0 of 1 | 0% |
| Ohio | 114 of 171 | 66.7% |
| Oklahoma | 54 of 81 | 66.7% |
| Oregon | 65 of 92 | 70.7% |
| Pennsylvania | 206 of 323 | 63.8% |
| Puerto Rico | 44 of 64 | 68.8% |
| Rhode Island | 10 of 29 | 34.5% |
| South Carolina | 59 of 89 | 66.3% |
| South Dakota | 14 of 30 | 46.7% |
| Tennessee | 109 of 156 | 69.9% |
| Texas | 259 of 407 | 63.6% |
| U.S. Virgin Islands | 0 of 1 | 0% |
| Utah | 30 of 53 | 56.6% |
| Vermont | 9 of 14 | 64.3% |
| Virginia | 95 of 144 | 66% |
| Washington | 74 of 114 | 64.9% |
| West Virginia | 46 of 69 | 66.7% |
| Wisconsin | 61 of 96 | 63.5% |
| Wyoming | 7 of 13 | 53.8% |
Medicare Part D paid for 339,561 30-day fills of Ubrelvy in 2024 for about 83,409 enrollees, at an average total cost of $1,241.39 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Ubrelvy and the rest of a client's list on every plan in their county.
Estimate Ubrelvy costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.